In March 2025, the company announced new strategies for the immediate-to-customer giving of its Wegovy weight loss drug. The company established a fresh pharmacy, named NovoCare, which would charge consumers $499 per 30 days for entry to the drug, fewer than 50 percent the expense of the drug by other pharmaceutical distribution networks.[53]Rybels